The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter. [electronic resource]
Producer: 20040720Description: 800-1 p. digitalISSN:- 1468-201X
- Adrenergic beta-Antagonists -- therapeutic use
- Carbazoles -- therapeutic use
- Cardiomyopathy, Dilated -- drug therapy
- Carvedilol
- Chronic Disease
- Echocardiography
- Humans
- Mitral Valve Insufficiency -- diagnostic imaging
- Propanolamines -- therapeutic use
- Retrospective Studies
- Ventricular Dysfunction, Left -- complications
- Ventricular Remodeling -- drug effects
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.